Hello Everyone, and Welcome to our new subscribers,
This morning we have a brand new alert that sits in a tight range that looks good to breakout from these price levels.
The stem cell industry is tipped to reach $170.15 BLN by 2020 and right now the industry is getting massive attention from Wall Street.
Our new alert is very established in the space and has presented itself as a solid bounce play just screaming at traders to take notice.
Want more? Let's get right to it.
Caribbean International Holdings Inc. - CIHN
Last Price: $0.0125
Website: http://www.regenerativebioscience.com/
CIHN Caribbean International Holdings Inc., through its subsidiary, Regenerative Bio Science, Inc., is engaged in the adult stem cell incubation and practice of regenerative medicine in the United States and the Dominican Republic.
CIHN treats cardiac and vascular patients with health problems, including congestive heart failure, coronary heart disease, cardiomyopathy, angina pectoris, peripheral artery disease, pulmonary fibrosis, and COPD.
CIHN’s physicians treat patients with ex-vivo generated autologous Angiogenic Cell Precursors (ACPs), which are derived from the patient’s own bone marrow aspirate taken from the pelvic bone.
CIHN was incorporated in 1939 and is based in Sarasota, Florida.
Global Stem Cell Industry to Hit $170.15 BLN By 2020 The global market for stem cells is expected to reach USD 170.15 BLN by 2020, according to a new study by Grand View Research, Inc. Growing prevalence of chronic diseases such as cardiovascular and liver disease, diabetes and cancer coupled with the presence of high unmet medical needs in these disease segments is expected to drive market growth during the forecast period.
Moreover, increasing government support pertaining to funding R&D initiatives and the growing demand for medical tourism and stem cell banking services is expected to boost the demand for stem cells over the next six years.
The stem cells technology market was valued at USD 12.88 BLN in 2013 and is expected to
grow at a CAGR of over 12.0% during the forecast period. This market was dominated by the cell acquisitions technology segment in terms of share in 2013 owing to the fact that this technology serves as the foremost step to process involving stem cells culture.
The global stem cell acquisition technology market is expected to reach USD 10.88 BLN by 2020, growing at a CAGR of over 14.0% over the next six years.
Recent Corporate Developments May 22nd: Caribbean International Holdings (CIHN) Plans Additions to Its Website May 20th: Caribbean International Holdings (CIHN) Releases Update On 22nd Annual World Congress on ANTI-AGING, REGENERATIVE & AESTHETIC MEDICINE, in Orlando, Florida
Begin your research on CIHN immediately and make sure you keep CIHN in full focus this morning!
Happy Trading,
Your AwesomeStocks.com Editor
Disclaimer
Please Read Carefully:
This newsletter is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances.
AwesomeStocks.com is a web property owned by Empire Investment Group Ltd. Empire Investment Group Ltd. has been compensated up to 10,000 USD for the release of this CIHN email by a third party.
Empire Investment Group Ltd. affiliates may at any time have a position in the securities mentioned herein and may increase or decrease such positions without notice which will negatively affect the market. Empire Investment Group Ltd. owns no shares of any companies mentioned in this email. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision.
While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of your investment.
